SILINTAN 25/pills recalled over undeclared meloxicam
- Recall date
- October 20, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- ANTHONY TRINH, 123Herbals LLC recalls SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
- Recall number
- D-0388-2026
- FDA classification
- Class I
- Brand / firm
- ANTHONY TRINH, 123Herbals LLC
- Sold / distributed
- USA nationwide
Why it was recalled
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Get recall alerts
Free email alert whenever ANTHONY TRINH, 123Herbals LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ANTHONY TRINH, 123Herbals LLC